Correlation Between GlaxoSmithKline PLC and Oramed Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Oramed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Oramed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Oramed Pharmaceuticals, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Oramed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Oramed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Oramed Pharmaceuticals.
Diversification Opportunities for GlaxoSmithKline PLC and Oramed Pharmaceuticals
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between GlaxoSmithKline and Oramed is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Oramed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oramed Pharmaceuticals and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Oramed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oramed Pharmaceuticals has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Oramed Pharmaceuticals go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Oramed Pharmaceuticals
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to generate 0.24 times more return on investment than Oramed Pharmaceuticals. However, GlaxoSmithKline PLC ADR is 4.11 times less risky than Oramed Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Oramed Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 3,251 in GlaxoSmithKline PLC ADR on August 26, 2024 and sell it today you would earn a total of 119.00 from holding GlaxoSmithKline PLC ADR or generate 3.66% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Oramed Pharmaceuticals
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Oramed Pharmaceuticals |
GlaxoSmithKline PLC and Oramed Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Oramed Pharmaceuticals
The main advantage of trading using opposite GlaxoSmithKline PLC and Oramed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Oramed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oramed Pharmaceuticals will offset losses from the drop in Oramed Pharmaceuticals' long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Oramed Pharmaceuticals vs. Capricor Therapeutics | Oramed Pharmaceuticals vs. Akari Therapeutics PLC | Oramed Pharmaceuticals vs. Soleno Therapeutics | Oramed Pharmaceuticals vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |